GPX4 and gastric cancer: Within the scope of this study, we identified that GPX4, a principal negative regulator of ferroptosis, is markedly overexpressed in gastric cancer patient tissues when compared to normal tissues, suggesting a critical role for GPX4 in enabling gastric cancer cells to evade ferroptosis.